Perspective Therapeutics (CATX) Institutional Ownership $3.90 +0.14 (+3.58%) As of 03:25 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Perspective Therapeutics (NYSEAMERICAN:CATX)CurrentInstitutional OwnershipPercentage54.66%Number ofInstitutional Buyers(last 12 months)50TotalInstitutional Inflows(last 12 months)$84.80MNumber ofInstitutional Sellers(last 12 months)28TotalInstitutional Outflows(last 12 months)$17.17M Get CATX Insider Trade Alerts Want to know when executives and insiders are buying or selling Perspective Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CATX Institutional Buying and Selling by Quarter Perspective Therapeutics Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE241,924$1.01M0.0%-43.0%0.212% 5/19/2026 Ally Bridge Group NY LLC926,557$3.86M3.1%N/A0.812% 5/18/2026 Yu Fan1,055,409$4.40M4.5%N/A0.925% 5/18/2026 ADAR1 Capital Management LLC749,335$3.13M0.2%+687.2%0.657% 5/16/2026 Quantinno Capital Management LP65,494$273K0.0%N/A0.057% 5/15/2026 Commodore Capital LP6,336,782$26.42M1.5%N/A5.556% 5/15/2026 Octagon Capital Advisors LP791,555$3.30M0.4%N/A0.694% 5/15/2026 Affinity Asset Advisors LLC3,164,582$13.20M0.7%+954.9%2.775% 5/15/2026 Spruce Street Capital LP2,627,107$10.96M2.6%N/A2.303% 5/7/2026 Dimensional Fund Advisors LP450,097$1.88M0.0%+391.6%0.395% Get the Latest News and Ratings for CATX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Perspective Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/5/2026 Bank of New York Mellon Corp185,335$773K0.0%-1.7%0.163% 4/28/2026 Abel Hall LLC11,794$49K0.0%N/A0.010% 4/21/2026 Wealth Effects LLC33,000$138K0.0%+32.0%0.029% 3/3/2026 Caitong International Asset Management Co. Ltd30,627$84K0.0%N/A0.041% 2/18/2026 XTX Topco Ltd82,476$227K0.0%+36.5%0.111% 2/18/2026 nVerses Capital LLC11,420$31K0.1%N/A0.015% 2/18/2026 Sphera Funds Management LTD.349,973$962K0.2%-31.4%0.471% 2/18/2026 Opaleye Management Inc.1,184,500$3.26M0.4%N/A1.593% 2/18/2026 Millennium Management LLC1,406,374$3.87M0.0%-45.1%1.892% 2/18/2026 Engineers Gate Manager LP12,562$35K0.0%N/A0.017% 2/17/2026 ADAR1 Capital Management LLC95,193$262K0.0%N/A0.128% 2/17/2026 Schonfeld Strategic Advisors LLC62,370$172K0.0%N/A0.084% 2/17/2026 Graham Capital Management L.P.80,193$221K0.0%+76.8%0.108% 2/16/2026 Avidity Partners Management LP3,210,733$8.83M2.5%+7.2%4.319% 2/16/2026 Barclays PLC92,791$255K0.0%+10.7%0.125% 2/16/2026 Aigen Investment Management LP10,173$28K0.0%N/A0.014% 2/13/2026 Marshall Wace LLP406,732$1.12M0.0%N/A0.547% 2/13/2026 The Manufacturers Life Insurance Company 19,031$52K0.0%-10.6%0.026% 2/13/2026 Walleye Capital LLC328,667$904K0.0%-39.8%0.442% 2/13/2026 State Street Corp1,141,247$3.14M0.0%+3.3%1.535% 2/13/2026 Vontobel Holding Ltd.25,000$69K0.0%+25.0%0.034% 2/13/2026 Caitong International Asset Management Co. Ltd15,208$42K0.1%N/A0.020% 2/13/2026 Wells Fargo & Company MN66,820$184K0.0%+46.2%0.090% 2/12/2026 MetLife Investment Management LLC16,717$46K0.0%-43.4%0.022% 2/12/2026 Renaissance Technologies LLC352,493$969K0.0%N/A0.474% 2/12/2026 Dimensional Fund Advisors LP91,557$252K0.0%N/A0.123% 2/12/2026 Federated Hermes Inc.213,759$588K0.0%+7.9%0.288% 2/12/2026 Patient Square Capital LP1,132,815$3.12M0.7%+224.3%1.524% 2/12/2026 Nuveen LLC1,274,007$3.50M0.0%-2.6%1.714% 2/11/2026 Deutsche Bank AG54,245$149K0.0%+6.1%0.073% Nobody Understands Why Trump Is Invading Iran (here’s the answer) (Ad)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.Discover the real reason behind the Iran strikes before markets react2/10/2026 Goldman Sachs Group Inc.159,837$440K0.0%-19.2%0.215% 2/10/2026 AXQ Capital LP12,749$35K0.0%+24.2%0.017% 2/10/2026 Intech Investment Management LLC25,702$71K0.0%-14.1%0.035% 2/9/2026 Geode Capital Management LLC1,414,522$3.89M0.0%-1.3%1.903% 2/5/2026 Hills Bank & Trust Co938,200$2.58M0.2%-4.2%1.262% 1/30/2026 R Squared Ltd15,991$44K0.0%N/A0.022% 1/29/2026 UBS Group AG926,331$2.55M0.0%+44.5%1.246% 1/21/2026 Trueblood Wealth Management LLC119,061$327K0.1%+72.4%0.160% 1/16/2026 Taylor & Morgan Wealth Management LLC97,000$267K0.1%+6.6%0.130% 1/14/2026 Auctus Advisors LLC31,673$87K0.1%N/A0.043% 1/1/2026 JPMorgan Chase & Co.436,357$1.50M0.0%-41.7%0.587% 11/17/2025 Susquehanna International Group LLP51,304$176K0.0%-55.9%0.069% 11/17/2025Sherbrooke Park Advisers LLC32,425$111K0.1%N/A0.044% 11/17/2025 Qube Research & Technologies Ltd68,959$237K0.0%-27.2%0.093% 11/17/2025 Mariner LLC86,116$295K0.0%+33.6%0.116% 11/17/2025 Mercer Global Advisors Inc. ADV29,275$100K0.0%+81.8%0.039% 11/17/2025 Millennium Management LLC2,561,112$8.79M0.0%-1.3%3.449% 11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.27,986$96K0.0%-14.2%0.038% 11/17/2025 Bank of America Corp DE785,823$2.70M0.0%+139.9%1.058% 11/14/2025 Two Sigma Investments LP519,668$1.78M0.0%-13.6%0.700% 11/14/2025 Bridgeway Capital Management LLC95,800$329K0.0%-13.5%0.129% 11/13/2025 UBS Group AG641,143$2.20M0.0%+72.0%0.863% 11/13/2025 BNP Paribas Financial Markets103,736$356K0.0%-57.2%0.140% 11/13/2025 Russell Investments Group Ltd.8,449$29K0.0%+184.1%0.011% 11/12/2025 Intech Investment Management LLC29,924$103K0.0%-23.3%0.040% 11/10/2025 AXQ Capital LP10,268$35K0.0%-49.9%0.014% 11/10/2025 Patient Square Capital LP349,323$1.20M0.3%N/A0.470% 11/10/2025Siligmueller & Norvid Wealth Advisors LLC164,711$565K0.3%N/A0.222% 11/7/2025Vanguard Group Inc.3,437,865$11.79M0.0%+5.0%4.629% 11/7/2025 JPMorgan Chase & Co.436,357$1.50M0.0%-41.7%0.588% 10/23/2025 SG Americas Securities LLC13,538$46K0.0%N/A0.018% 10/15/2025 Taylor & Morgan Wealth Management LLC91,000$312K0.2%-3.2%0.123% 10/9/2025 Voya Investment Management LLC10,675$37K0.0%-35.5%0.014% 8/15/2025 Engineers Gate Manager LP28,708$99K0.0%-75.9%0.039% 8/15/2025 BNP Paribas Financial Markets242,610$835K0.0%+227.1%0.327% 8/15/2025 Bridgeway Capital Management LLC110,800$381K0.0%-11.4%0.149% 8/15/2025 Bank of America Corp DE327,500$1.13M0.0%+8.5%0.441% 8/14/2025 Qube Research & Technologies Ltd94,693$326K0.0%-22.4%0.128% 8/14/2025 Federated Hermes Inc.195,080$671K0.0%+44.4%0.263% 8/13/2025 Affinity Asset Advisors LLC1,050,000$3.61M0.5%-52.8%1.415% 8/13/2025 Marshall Wace LLP520,707$1.79M0.0%-54.1%0.701% 8/13/2025 Walleye Capital LLC187,403$645K0.0%+375.8%0.252% 8/12/2025 Rhumbline Advisers83,250$286K0.0%-15.2%0.112% 8/12/2025 JPMorgan Chase & Co.748,067$2.57M0.0%+118.4%1.008% 8/8/2025 Citizens Financial Group Inc. RI53,100$183K0.0%-46.9%0.072% 8/8/2025 Geode Capital Management LLC1,382,814$4.76M0.0%+15.8%1.863% 8/7/2025 Los Angeles Capital Management LLC17,595$61K0.0%N/A0.024% 8/5/2025 Hills Bank & Trust Co984,200$3.39M0.2%-3.9%1.326% 7/31/2025 Ground Swell Capital LLC16,373$56K0.1%N/A0.022% 7/29/2025 Nicholson Wealth Management Group LLC1,614,283$5.55M3.4%+0.3%2.175% SpaceX eyes a 1.75 trillion valuation - here's what to know (Ad)Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.See how to get positioned in SpaceX before the announcement goes public7/23/2025 Trueblood Wealth Management LLC69,061$238K0.1%+210.6%0.093% 7/15/2025 Wealth Effects LLC24,000$83K0.0%-38.5%0.032% 7/7/2025 Taylor & Morgan Wealth Management LLC94,000$323K0.2%+4.4%0.127% 6/27/2025 Goldman Sachs Group Inc.302,819$645K0.0%-66.5%0.408% 5/16/2025Octagon Capital Advisors LP2,250,000$4.79M0.5%-2.4%3.038% 5/16/2025Goldman Sachs Group Inc.302,819$645K0.0%-66.5%0.409% 5/15/2025Cubist Systematic Strategies LLC51,480$110K0.0%-80.3%0.070% 5/14/2025Affinity Asset Advisors LLC2,224,196$4.74M0.5%+71.1%3.004% 5/14/2025MetLife Investment Management LLC31,310$67K0.0%+40.9%0.042% 5/14/2025Walleye Capital LLC39,390$84K0.0%-91.7%0.053% CATX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CATX shares? During the previous two years, 125 institutional investors and hedge funds held shares of Perspective Therapeutics. The most heavily invested institutionals were FMR LLC ($73.49M), Commodore Capital LP ($26.42M), Affinity Asset Advisors LLC ($13.20M), Vanguard Group Inc. ($11.79M), Spruce Street Capital LP ($10.96M), Deerfield Management Company L.P. Series C ($9.38M), and Avidity Partners Management LP ($8.83M).Learn more on Perspective Therapeutics' institutional investors. What percentage of Perspective Therapeutics' stock is owned by institutional investors? 54.66% of Perspective Therapeutics' stock is owned by institutional investors. Learn more on CATX's institutional investor holdings. Which institutional investors have been buying Perspective Therapeutics' stock? Of the 105 institutional investors that purchased Perspective Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Commodore Capital LP ($6.34M), FMR LLC ($5.37M), Affinity Asset Advisors LLC ($4.59M), Spruce Street Capital LP ($2.63M), Octagon Capital Advisors LP ($1.67M), Nicholson Wealth Management Group LLC ($1.61M), and Ally Bridge Group NY LLC ($1.32M). How much institutional buying is happening at Perspective Therapeutics? Institutional investors have bought a total of 22,088,573 shares in the last 24 months. This purchase volume represents approximately $84.80M in transactions. Which of Perspective Therapeutics' major shareholders have been selling company stock? Of the 28 institutional investors that sold Perspective Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($1.19M), Affinity Asset Advisors LLC ($1.17M), Goldman Sachs Group Inc. ($637.97K), JPMorgan Chase & Co. ($623.42K), Marshall Wace LLP ($614.74K), Walleye Capital LLC ($217.37K), and Bank of America Corp DE ($182.60K). How much institutional selling is happening at Perspective Therapeutics? Institutional investors have sold a total of 5,521,652 shares in the last 24 months. This volume of shares sold represents approximately $17.17M in transactions. Related Companies ENOV Major Shareholders PRCT Major Shareholders EYE Major Shareholders CDRE Major Shareholders KMTS Major Shareholders INSP Major Shareholders AVNS Major Shareholders AORT Major Shareholders IRMD Major Shareholders CNMD Major Shareholders This page (NYSEAMERICAN:CATX) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perspective Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Perspective Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
